SCHEMBL31542082

SCHEMBL31542082

COC(=O)c1ccc(Cc2nc3ccccc3c(=O)n2-c2ccc(Cl)cc2)cc1

nearest known ligand 0.63

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.63
DRD2 P14416 4/20 0.62
TBXA2R P21731 4/20 0.62
ALDH1A1 P00352 5/20 0.62
NPC1 O15118 1/20 0.59
RAB9A P51151 1/20 0.59
KMT2A Q03164 4/20 0.57
MEN1 O00255 3/20 0.57
SMN1; SMN2 Q16637 2/20 0.57
BLM P54132 1/20 0.57
PDE10A Q9Y233 1/20 0.57
NPSR1 Q6W5P4 1/20 0.49
HTR7 P34969 1/20 0.49
TSHR P16473 2/20 0.48
CYP1A2 P05177 2/20 0.48
CYP3A4 P08684 2/20 0.48
CYP2C9 P11712 2/20 0.48
CYP2C19 P33261 2/20 0.48
CYP2D6 P10635 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31542084 0.90 ALDH1A1 (0.78) POLBALDH1A1NPC1RAB9AKMT2A
SCHEMBL31542064 0.87 ALDH1A1 (0.61) ALDH1A1NPC1RAB9AKMT2AMEN1
SCHEMBL31542077 0.86 ALDH1A1 (0.57) POLBDRD2TBXA2RALDH1A1NPC1
SCHEMBL31542083 0.82 POLB (0.56) POLBDRD2TBXA2RALDH1A1NPC1
SCHEMBL4958333 0.80 LMNA (0.73) POLBALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL31542069 0.80 ALDH1A1 (0.75) ALDH1A1NPC1RAB9AKMT2AMEN1
SCHEMBL31542055 0.78 NPC1 (0.70) ALDH1A1NPC1RAB9AKMT2AMEN1
SCHEMBL7018781 0.78 ALDH1A1 (0.60) ALDH1A1NPC1RAB9AKMT2AMEN1
SCHEMBL447996 0.77 HTR7 (0.59) ALDH1A1NPC1RAB9AKMT2AMEN1
SCHEMBL31542078 0.77 POLB (0.51) POLBDRD2TBXA2RALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4622964-A1 QUINAZOLINONE DERIVATIVES FOR HDAC INHIBITION Gilva Therapeutics Co., Ltd. (TW) 2025-10-01 EP disclosed
WO-2025085669-A1 QUINAZOLINONE DERIVATIVES FOR HDAC INHIBITION GILVA THERAPEUTICS CO., LTD. (CN) 2025-04-24 WO disclosed